Form D · Pharmaceuticals

Nightingale Pharmaceuticals, Inc.

National City, CA · CIK 0001635548

Offering snapshot reported Mar 25, 2016 · SEC filing

Reported sold
$1.67M
Offering amount: $2M
Investors reported
19
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Feb 27, 2015
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$833K$1.67MMar 6, 2015: $375,000.00Mar 6, 2015Mar 25, 2016: $1,665,000.00Mar 25, 2016

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$375,000 → $1,665,000
  • Reported investors1 → 19
  • Minimum accepted$125,000 → $10,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 25, 2016Amendment$1,665,000$1,290,000vs Mar 6, 201519SEC filing
Mar 6, 2015Initial$375,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-235337

Source: Form D, filed Mar 25, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Melwyn Abreo Director, Executive
Lorens Attisha Director, Executive
David Church Director, Executive
Carol Mcbride Director, Executive
Talal (Brian) Sheena Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
1999 Sweetwater Rd.
National City, CA, 91950